Creative Planning’s DexCom DXCM Stock Holding History

Creative Planning’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,000	Closed	-$2K	–	2181
2020 Q2	$2K	Buy	+2,000	New	+$179K	﹤0.01%	1951

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Creative Planning's DXCM Position: Q2 2026 in Review

Creative Planning increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $1.6M and bringing the position to 123,334 shares worth $8.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Creative Planning first reported a position in DXCM in Q1 2015 and has held it in 43 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Creative Planning held 123,334 shares of DexCom worth $8.31M as of Q2 2026.
Creative Planning bought 23,980 DexCom shares in Q2 2026, an estimated $1.6M.
DexCom made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1022 holding.
Creative Planning first reported a position in DexCom in Q1 2015 and has held it in 43 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.